|
Jun 25
|
Newron Pharmaceuticals Reports on Its 2024 Investor Day in New York City
|
|
Jun 18
|
Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City
|
|
Dec 29
|
Newron Completes Enrollment of Schizophrenia Patients in Potentially Pivotal Study 008A With Evenamide
|
|
Aug 4
|
Newron Announces H1 2023 Results and Provides R&D Update
|